ProMab is a biotech company developing recombinant proteins and custom monoclonal antibodies through the integration of bioinformatics, gene cloning, protein expression and purification, and immunology, using novel high-throughput technologies.
ProMab is a biotech company developing recombinant proteins and custom monoclonal antibodies through the integration of bioinformatics, gene cloning, protein expression and purification, and immunology, using novel high-throughput technologies.
Abgent is a biotech company manufacturing primary antibodies with more than a decade of experience. Most of Abgent’s antibodies are produced in-house to ensure high specificity, affinity, and reproducibility.